The University of Iowa
The University of Iowa News Services Home News Releases UI in the News Subscribe to UI News Contact Us
2130 Medical Laboratories
Iowa City IA 52242
(319) 335-8032; fax (319) 335-8034

Release: March 8, 1999

Linhardt to receive prestigious research achievement award

IOWA CITY, Iowa -- Robert J. Linhardt, Ph.D., professor of medicinal and natural products chemistry at the University of Iowa College of Pharmacy, has been named the 1999 recipient of the Volwiler Research Achievement Award from the American Association of Colleges of Pharmacy (AACP).

Sponsored by Abbott Laboratories in memory of its former president and research director, Ernest H. Volwiler, the association's premier research award consists of a $12,500 cash prize, a gold medal and an inscribed plaque. Linhardt will receive the award at the AACP's centennial meeting awards banquet July 6 in Boston.

Linhardt's research focuses on the study of bioactive carbohydrates. His principal research projects involve heparin, a major clinical anticoagulant with more than 500 million doses used worldwide. Linhardt has helped develop derivatives of the blood-thinning medication--used frequently during surgery--that are safer and more effective.

His 1983 paper published in the journal Science, describing a newly discovered, heparin-associated antiangiogenic activity, is considered a landmark publication. The article, written with Judah Folkman of Harvard, has been cited nearly 1,000 times in the past 15 years and has led to a new class of experimental therapeutic agents.

Linhardt, the UI's F. Wendell Miller Distinguished Professor of Pharmacy, received his Ph.D. in organic chemistry from Johns Hopkins University in 1979. A UI faculty member since 1982, he has published more than 200 research papers, has been awarded 23 patents and has presented more than 250 seminars both nationally and internationally.

The AACP is the national organization representing all U.S. schools and colleges of pharmacy and is dedicated to education and scholarship for improving drug therapy.